| Plasma DNA end-motif profiling as a fragmentomic marker in cancer, pregnancy, and transplantation P Jiang, K Sun, W Peng, SH Cheng, M Ni, PC Yeung, MMS Heung, T Xie, ... Cancer Discovery 10 (5), 664-673, 2020 | 221 | 2020 |
| Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma M Liu, J Zhou, X Liu, Y Feng, W Yang, F Wu, OKW Cheung, H Sun, ... Gut 69 (2), 365-379, 2020 | 150 | 2020 |
| Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver W Tang, J Zhou, W Yang, Y Feng, H Wu, MTS Mok, L Zhang, Z Liang, ... Cellular & Molecular Immunology 19 (7), 834-847, 2022 | 53 | 2022 |
| Presence of donor-derived DNA and cells in the urine of sex-mismatched hematopoietic stem cell transplant recipients: implication for the transrenal hypothesis ECW Hung, TKF Shing, SSC Chim, PC Yeung, RWY Chan, KW Chik, ... Clinical chemistry 55 (4), 715-722, 2009 | 36 | 2009 |
| Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis X Zeng, J Zhou, Z Xiong, H Sun, W Yang, MTS Mok, J Wang, J Li, M Liu, ... Cellular & Molecular Immunology 18 (4), 1005-1015, 2021 | 33 | 2021 |
| Measuring fragmentation of ambulatory care in a tripartite healthcare system S Liu, PC Yeung BMC Health services research 13, 1-10, 2013 | 19 | 2013 |
| Rates and risk factors associated with the progression of HIV to AIDS among HIV patients from Zhejiang, China between 2008 and 2012 L Chen, J Yang, R Zhang, Y Xu, J Zheng, J Jiang, J Jiang, L He, N Wang, ... AIDS Research and Therapy 12, 1-8, 2015 | 11 | 2015 |
| Genetic variation in ABCB5 associates with risk of hepatocellular carcinoma ICY Leung, CCN Chong, TT Cheung, PC Yeung, KKC Ng, PBS Lai, ... Journal of Cellular and Molecular Medicine 24 (18), 10705-10713, 2020 | 6 | 2020 |
| Protocol for isolating human BCAM-positive corneal progenitor cells by flow cytometry and cell sorting Y Sasamoto, PC Yeung, J Tran, MH Frank, NY Frank STAR protocols 4 (3), 102503, 2023 | | 2023 |
| ABCF1 and ABCF2 genetic variants in association with hepatocellular carcinoma (HCC) risk PC Yeung, KKC Ng, TT Cheung, CCN Chong, PBS Lai, ST Cheung Cancer Research 82 (12_Supplement), 1436-1436, 2022 | | 2022 |
| Asian prevalent ABCB5 genetic variants rs2074000 and rs17143187 predicts overall survival and clinical outcomes in hepatocellular carcinoma patients CP Yeung, CNC Chong, TT Cheung, KKC Ng, PBS Lai, ST Cheung Cancer Research 81 (13_Supplement), 807-807, 2021 | | 2021 |
| IDDF2020-ABS-0209 Asian prevalent allele at ABCB5 SNP Rs10254317 associates with hepatocellular carcinoma (HCC) risk and adverse clinical outcomes PC Yeung, CCN Chong, TT Cheung, KKC Ng, PBS Lai, ST Cheung Gut 69 (Suppl 2), A26-A26, 2020 | | 2020 |
| IDDF2020-ABS-0210 Statin use associated with reduced risk of all-cause mortality in hepatocellular carcinoma patients following liver resection: a systematic review and meta … PC Yeung, ST Cheung, KKC Ng, PBS Lai, CCN Chong Gut 69 (Suppl 2), A89-A90, 2020 | | 2020 |
| STAT3 regulates chemo-resistance and cancer stemness in hepatocellular carcinoma C Lee, EYL Or, CCN Chong, TT Cheung, IMJ Xu, LWC Ng, MHL Law, ... Cancer Research 80 (16_Supplement), 4151-4151, 2020 | | 2020 |
| Statin use associated with reduced risk of hepatocellular carcinoma recurrence following liver resection: A systematic review and meta-analysis CP Yeung, ST Cheung, KCK Ng, BSP Lai, CNC Chong Cancer Research 80 (16_Supplement), 2345-2345, 2020 | | 2020 |
| IDDF2019-ABS-0174 Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma M Liu, J Zhou, X Liu, Y Feng, W Yang, F Wu, OKW Cheung, H Sun, ... Gut 68 (Suppl 1), A2-A3, 2019 | | 2019 |
| The Effect of Converting the Surgical Ambulatory Care Centre into a 24-hour Inpatient Ward on Length of Stay at the Emergency Department among General Surgical Patients. PC Yeung, ST Chui, CCN Chong, YS Cheung, AHM Chan, PBS Lai Hospital Authority Convention 2018, Hong Kong., 2018 | | 2018 |
| Multidisciplinary Surgical Site Infection Reduction Measures - a Single Centre Experience. K Futaba, PC Yeung, SF Tang, PBS Lai, JFY Lee, SM Ng, TWC Mak Hospital Authority Convention 2017, Hong Kong., 2017 | | 2017 |
| Changing Experience of Antiviral Therapy for Chronic Hepatitis B Patients in Hong Kong. N Leung, AJ Hui, R Chan, C Yeung, G Leung, KLY Lam Hepatology International 4 (1), 156, 2010 | | 2010 |
| Do Chronic Hepatitis B (CHB) Patients with Negative HBeAg and Serum HBV-DNA at or Below 4log10IU/L Have Stable Viral Level and Non-Progressive Liver Disease? N Leung, C Yeung, R Chan, SM Au, H Poon, AJ Hui, KW Choi Hepatology International 3 (1), 122, 2009 | | 2009 |
